Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
Nilotinib 3-Imidazolyl N-Difluoroboryloxide is an intermediate for the synthesis of Nilotinib 3-Imidazolyl N-oxide (M326296), which is an impurity compound of Nilotinib (N465300), useful in the treatment of chronic myelogenous leukemia.